摘要 |
The present invention is concerned with aryl-isoxazol-4-yl-imidazole derivatives of formula (I), wherein R<SUP>1</SUP> to R<SUP>3</SUP> are each independently hydrogen or halogen; R<SUP>4</SUP> is hydrogen, lower alkyl, cycloalkyl, -(CH<SUB>2</SUB>)<SUB>n</SUB>-O-lower alkyl or lower alkyl substituted by hydroxy; R<SUP>5</SUP> is -(CH<SUB>2</SUB>)<SUB>m</SUB>-aryl or -(CH<SUB>2</SUB>)<SUB>m</SUB>-heteroaryl which are optionally substituted by one or more substituents selected from the group consisting of halogen, cyano, nitro, lower alkyl, lower alkoxy, lower alkylsulfanyl, lower alkyl substituted by halogen, -C(O)-lower alkyl, -C(O)-O-lower alkyl, -NH-C(O)-O-lower alkyl or -C(O)-NH-R', wherein R' is lower alkynyl or lower alkyl substituted by halogen, or is -(CH<SUB>2</SUB>)<SUB>n</SUB>-cycloalkyl, -(CH<SUB>2</SUB>)<SUB>n</SUB>-heterocyclyl, -(CH<SUB>2</SUB>)<SUB>n</SUB>-heteroaryl or -(CH<SUB>2</SUB>)<SUB>n</SUB>-aryl, optionally substituted by halogen; R<SUP>6</SUP> is hydrogen, -C(O)H, -(CH<SUB>2</SUB>)<SUB>n</SUB>-O-lower alkyl, -C(O)O-lower alkyl, lower alkyl substituted by hydroxy or halogen, or is cycloalkyl, aryl, or is -(CH<SUB>2</SUB>)<SUB>n</SUB>-O-CH<SUB>2</SUB>-aryl, optionally substituted by halogen or lower alkyl, or is -(CH<SUB>2</SUB>)<SUB>n</SUB>-O-CH<SUB>2</SUB>-heteroaryl, optionally substituted by halogen, lower alkyl or lower alkyl substituted by halogen, or is -(CH<SUB>2</SUB>)<SUB>n</SUB>-NH-(CH<SUB>2</SUB>)<SUB>o</SUB>-heterocyclyl; n is 0, 1, 2 or 3 m is 0 or 1; o is 1, 2 or 3; as well as with pharmaceutically acceptable acid addition salts thereof. It has been found that this class of compounds show high affinity and selectivity for GABA A a5 receptor binding sites and might be useful as cognitive enhancer or for the treatment of cognitive disorders like Alzheimer's disease. |
申请人 |
F. HOFFMANN-LA ROCHE AG;BUETTELMANN, BERND;HAN, BO;KNUST, HENNER;THOMAS, ANDREW |
发明人 |
BUETTELMANN, BERND;HAN, BO;KNUST, HENNER;THOMAS, ANDREW |